Motif 1207 (n=42)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
B2RUZ4 | SMIM1 | S6 | ochoa | Small integral membrane protein 1 (Vel blood group antigen) | Regulator of red blood cell formation. {ECO:0000250|UniProtKB:B3DHH5}. |
O00161 | SNAP23 | S6 | ochoa|psp | Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23) | Essential component of the high affinity receptor for the general membrane fusion machinery and an important regulator of transport vesicle docking and fusion. |
O43242 | PSMD3 | S6 | psp | 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) | Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. {ECO:0000269|PubMed:1317798}. |
O43791 | SPOP | S6 | ochoa|psp | Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1) | Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates the ubiquitination of target proteins, leading most often to their proteasomal degradation. In complex with CUL3, involved in ubiquitination and proteasomal degradation of BRMS1, DAXX, PDX1/IPF1, GLI2 and GLI3. In complex with CUL3, involved in ubiquitination of MACROH2A1 and BMI1; this does not lead to their proteasomal degradation. Inhibits transcriptional activation of PDX1/IPF1 targets, such as insulin, by promoting PDX1/IPF1 degradation. The cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex containing homodimeric SPOP has higher ubiquitin ligase activity than the complex that contains the heterodimer formed by SPOP and SPOPL. Involved in the regulation of bromodomain and extra-terminal motif (BET) proteins BRD2, BRD3, BRD4 stability (PubMed:32109420). Plays an essential role for proper translation, but not for their degradation, of critical DNA replication licensing factors CDT1 and CDC6, thereby participating in DNA synthesis and cell proliferation (PubMed:36791496). Regulates interferon regulatory factor 1/IRF1 proteasomal turnover by targeting S/T-rich degrons in IRF1 (PubMed:37622993). Facilitates the lysosome-dependent degradation of enterovirus EV71 protease 2A by inducing its 'Lys-48'-linked polyubiquitination, which ultimately restricts EV71 replication (PubMed:37796126). Acts as an antiviral factor also against hepatitis B virus/HBV by promoting ubiquitination and subsequent degradation of HNF1A (PubMed:38018242). In turn, inhibits HBV transcription and replication by preventing HNF1A stimulating activity of HBV preS1 promoter and enhancer II (PubMed:38018242). Involved in ubiquitination of BRDT and promotes its degradation, thereby regulates histone removal in early condensing spermatids prior to histone-to-protamine exchange (By similarity). {ECO:0000250|UniProtKB:Q6ZWS8, ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:16524876, ECO:0000269|PubMed:19818708, ECO:0000269|PubMed:22085717, ECO:0000269|PubMed:22632832, ECO:0000269|PubMed:32109420, ECO:0000269|PubMed:37622993, ECO:0000269|PubMed:37796126, ECO:0000269|PubMed:38018242}. |
O76021 | RSL1D1 | S6 | ochoa | Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1) | Regulates cellular senescence through inhibition of PTEN translation. Acts as a pro-apoptotic regulator in response to DNA damage. {ECO:0000269|PubMed:18678645, ECO:0000269|PubMed:22419112}. |
O94806 | PRKD3 | S6 | ochoa | Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu) | Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. Involved in resistance to oxidative stress (By similarity). {ECO:0000250}. |
P04632 | CAPNS1 | S6 | ochoa | Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit) | Regulatory subunit of the calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. Essential for embryonic development (By similarity). {ECO:0000250|UniProtKB:O88456}. |
P09651 | HNRNPA1 | S6 | ochoa|psp | Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed] | Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and modulation of splice site selection (PubMed:17371836). Plays a role in the splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed:20010808). Binds to the IRES and thereby inhibits the translation of the apoptosis protease activating factor APAF1 (PubMed:31498791). May bind to specific miRNA hairpins (PubMed:28431233). {ECO:0000269|PubMed:17371836, ECO:0000269|PubMed:20010808, ECO:0000269|PubMed:28431233, ECO:0000269|PubMed:31498791}.; FUNCTION: (Microbial infection) May play a role in HCV RNA replication. {ECO:0000269|PubMed:17229681}.; FUNCTION: (Microbial infection) Cleavage by Enterovirus 71 protease 3C results in increased translation of apoptosis protease activating factor APAF1, leading to apoptosis. {ECO:0000269|PubMed:17229681}. |
P17844 | DDX5 | S6 | ochoa | Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68) | Involved in the alternative regulation of pre-mRNA splicing; its RNA helicase activity is necessary for increasing tau exon 10 inclusion and occurs in a RBM4-dependent manner. Binds to the tau pre-mRNA in the stem-loop region downstream of exon 10. The rate of ATP hydrolysis is highly stimulated by single-stranded RNA. Involved in transcriptional regulation; the function is independent of the RNA helicase activity. Transcriptional coactivator for androgen receptor AR but probably not ESR1. Synergizes with DDX17 and SRA1 RNA to activate MYOD1 transcriptional activity and involved in skeletal muscle differentiation. Transcriptional coactivator for p53/TP53 and involved in p53/TP53 transcriptional response to DNA damage and p53/TP53-dependent apoptosis. Transcriptional coactivator for RUNX2 and involved in regulation of osteoblast differentiation. Acts as a transcriptional repressor in a promoter-specific manner; the function probably involves association with histone deacetylases, such as HDAC1. As component of a large PER complex is involved in the inhibition of 3' transcriptional termination of circadian target genes such as PER1 and NR1D1 and the control of the circadian rhythms. {ECO:0000269|PubMed:12527917, ECO:0000269|PubMed:15298701, ECO:0000269|PubMed:15660129, ECO:0000269|PubMed:17011493, ECO:0000269|PubMed:17960593, ECO:0000269|PubMed:18829551, ECO:0000269|PubMed:19718048, ECO:0000269|PubMed:21343338}. |
P19174 | PLCG1 | S6 | ochoa | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1) | Mediates the production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). Plays an important role in the regulation of intracellular signaling cascades. Becomes activated in response to ligand-mediated activation of receptor-type tyrosine kinases, such as PDGFRA, PDGFRB, EGFR, FGFR1, FGFR2, FGFR3 and FGFR4 (By similarity). Plays a role in actin reorganization and cell migration (PubMed:17229814). Guanine nucleotide exchange factor that binds the GTPase DNM1 and catalyzes the dissociation of GDP, allowing a GTP molecule to bind in its place, therefore enhancing DNM1-dependent endocytosis (By similarity). {ECO:0000250|UniProtKB:P10686, ECO:0000269|PubMed:17229814, ECO:0000269|PubMed:37422272}. |
P33991 | MCM4 | S6 | ochoa | DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:16899510, PubMed:25661590, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232, PubMed:9305914). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:16899510, PubMed:25661590, PubMed:32453425, PubMed:9305914). {ECO:0000269|PubMed:16899510, ECO:0000269|PubMed:25661590, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000269|PubMed:9305914}. |
Q07869 | PPARA | S6 | psp | Peroxisome proliferator-activated receptor alpha (PPAR-alpha) (Nuclear receptor subfamily 1 group C member 1) | Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as a transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2. May be required for the propagation of clock information to metabolic pathways regulated by PER2. {ECO:0000269|PubMed:10195690, ECO:0000269|PubMed:24043310, ECO:0000269|PubMed:7629123, ECO:0000269|PubMed:7684926, ECO:0000269|PubMed:9556573}. |
Q13522 | PPP1R1A | S6 | ochoa | Protein phosphatase 1 regulatory subunit 1A (Protein phosphatase inhibitor 1) (I-1) (IPP-1) | Inhibitor of protein-phosphatase 1. This protein may be important in hormonal control of glycogen metabolism. Hormones that elevate intracellular cAMP increase I-1 activity in many tissues. I-1 activation may impose cAMP control over proteins that are not directly phosphorylated by PKA. Following a rise in intracellular calcium, I-1 is inactivated by calcineurin (or PP2B). Does not inhibit type-2 phosphatases. |
Q14451 | GRB7 | S6 | ochoa | Growth factor receptor-bound protein 7 (B47) (Epidermal growth factor receptor GRB-7) (GRB7 adapter protein) | Adapter protein that interacts with the cytoplasmic domain of numerous receptor kinases and modulates down-stream signaling. Promotes activation of down-stream protein kinases, including STAT3, AKT1, MAPK1 and/or MAPK3. Promotes activation of HRAS. Plays a role in signal transduction in response to EGF. Plays a role in the regulation of cell proliferation and cell migration. Plays a role in the assembly and stability of RNA stress granules. Binds to the 5'UTR of target mRNA molecules and represses translation of target mRNA species, when not phosphorylated. Phosphorylation impairs RNA binding and promotes stress granule disassembly during recovery after cellular stress (By similarity). {ECO:0000250, ECO:0000269|PubMed:10893408, ECO:0000269|PubMed:12021278, ECO:0000269|PubMed:12223469, ECO:0000269|PubMed:20622016}. |
Q15742 | NAB2 | S6 | ochoa | NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein) (Protein MADER) | Acts as a transcriptional repressor for zinc finger transcription factors EGR1 and EGR2. Isoform 2 lacks repression ability (By similarity). {ECO:0000250}. |
Q15911 | ZFHX3 | S6 | ochoa | Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3) (ZFH-3) | Transcriptional regulator which can act as an activator or a repressor. Inhibits the enhancer element of the AFP gene by binding to its AT-rich core sequence. In concert with SMAD-dependent TGF-beta signaling can repress the transcription of AFP via its interaction with SMAD2/3 (PubMed:25105025). Regulates the circadian locomotor rhythms via transcriptional activation of neuropeptidergic genes which are essential for intercellular synchrony and rhythm amplitude in the suprachiasmatic nucleus (SCN) of the brain (By similarity). Regulator of myoblasts differentiation through the binding to the AT-rich sequence of MYF6 promoter and promoter repression (PubMed:11312261). Down-regulates the MUC5AC promoter in gastric cancer (PubMed:17330845). In association with RUNX3, up-regulates CDKN1A promoter activity following TGF-beta stimulation (PubMed:20599712). Inhibits estrogen receptor (ESR1) function by selectively competing with coactivator NCOA3 for binding to ESR1 in ESR1-positive breast cancer cells (PubMed:20720010). {ECO:0000250|UniProtKB:Q61329, ECO:0000269|PubMed:11312261, ECO:0000269|PubMed:17330845, ECO:0000269|PubMed:20599712, ECO:0000269|PubMed:20720010, ECO:0000269|PubMed:25105025}. |
Q5BKX5 | ACTMAP | S6 | ochoa | Actin maturation protease (EC 3.4.11.-) (Actin aminopeptidase ACTMAP) | Actin maturation protease that specifically mediates the cleavage of immature acetylated N-terminal actin, thereby contributing to actin maturation (PubMed:36173861). Cleaves N-terminal acetylated methionine of immature cytoplasmic beta- and gamma-actins ACTB and ACTG1 after translation (PubMed:36173861). Cleaves N-terminal acetylated cysteine of muscle alpha-actins ACTA1, ACTC1 and ACTA2 after canonical removal of N-terminal methionine (By similarity). {ECO:0000250|UniProtKB:J3QPC3, ECO:0000269|PubMed:36173861}. |
Q5I0X4 | PEX39 | S6 | ochoa | Peroxisomal biogenesis factor 39 | May be a peroxin involved in the PTS2-mediated protein import pathway. {ECO:0000305|PubMed:37160800}. |
Q6NSJ2 | PHLDB3 | S6 | ochoa | Pleckstrin homology-like domain family B member 3 | None |
Q6PCB5 | RSBN1L | S6 | ochoa | Lysine-specific demethylase RSBN1L (EC 1.14.11.-) (Round spermatid basic protein 1-like protein) | Lysine-specific demethylase that specifically demethylates methylated lysine residues of proteins. {ECO:0000250|UniProtKB:Q80T69}. |
Q7KZI7 | MARK2 | T6 | ochoa | Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) | Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. {ECO:0000269|PubMed:11433294, ECO:0000269|PubMed:12429843, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15158914, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:15365179, ECO:0000269|PubMed:16775013, ECO:0000269|PubMed:16980613, ECO:0000269|PubMed:18626018, ECO:0000269|PubMed:20194617, ECO:0000269|PubMed:23666762}. |
Q86UP3 | ZFHX4 | S6 | ochoa | Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4) | May play a role in neural and muscle differentiation (By similarity). May be involved in transcriptional regulation. {ECO:0000250}. |
Q86VM9 | ZC3H18 | S6 | ochoa | Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1) | None |
Q8N568 | DCLK2 | S6 | ochoa | Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) | Protein kinase with a significantly reduced C(a2+)/CAM affinity and dependence compared to other members of the CaMK family. May play a role in the down-regulation of CRE-dependent gene activation probably by phosphorylation of the CREB coactivator CRTC2/TORC2 and the resulting retention of TORC2 in the cytoplasm (By similarity). {ECO:0000250}. |
Q8WYQ5 | DGCR8 | S6 | ochoa | Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8) | Component of the microprocessor complex that acts as a RNA- and heme-binding protein that is involved in the initial step of microRNA (miRNA) biogenesis. Component of the microprocessor complex that is required to process primary miRNA transcripts (pri-miRNAs) to release precursor miRNA (pre-miRNA) in the nucleus. Within the microprocessor complex, DGCR8 function as a molecular anchor necessary for the recognition of pri-miRNA at dsRNA-ssRNA junction and directs DROSHA to cleave 11 bp away form the junction to release hairpin-shaped pre-miRNAs that are subsequently cut by the cytoplasmic DICER to generate mature miRNAs (PubMed:26027739, PubMed:26748718). The heme-bound DGCR8 dimer binds pri-miRNAs as a cooperative trimer (of dimers) and is active in triggering pri-miRNA cleavage, whereas the heme-free DGCR8 monomer binds pri-miRNAs as a dimer and is much less active. Both double-stranded and single-stranded regions of a pri-miRNA are required for its binding (PubMed:15531877, PubMed:15574589, PubMed:15589161, PubMed:16751099, PubMed:16906129, PubMed:16963499, PubMed:17159994). Specifically recognizes and binds N6-methyladenosine (m6A)-containing pri-miRNAs, a modification required for pri-miRNAs processing (PubMed:25799998). Involved in the silencing of embryonic stem cell self-renewal (By similarity). Also plays a role in DNA repair by promoting the recruitment of RNF168 to RNF8 and MDC1 at DNA double-strand breaks and subsequently the clearance of DNA breaks (PubMed:34188037). {ECO:0000250|UniProtKB:Q9EQM6, ECO:0000269|PubMed:15531877, ECO:0000269|PubMed:15574589, ECO:0000269|PubMed:15589161, ECO:0000269|PubMed:16751099, ECO:0000269|PubMed:16906129, ECO:0000269|PubMed:16963499, ECO:0000269|PubMed:17159994, ECO:0000269|PubMed:25799998, ECO:0000269|PubMed:26027739, ECO:0000269|PubMed:26748718}. |
Q96AE4 | FUBP1 | T6 | ochoa | Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) | Regulates MYC expression by binding to a single-stranded far-upstream element (FUSE) upstream of the MYC promoter. May act both as activator and repressor of transcription. {ECO:0000269|PubMed:8125259}. |
Q96DG6 | CMBL | Y6 | ochoa | Carboxymethylenebutenolidase homolog (EC 3.1.-.-) | Cysteine hydrolase. Can convert the prodrug olmesartan medoxomil into its pharmacologically active metabolite olmerstatan, an angiotensin receptor blocker, in liver and intestine. May also activate beta-lactam antibiotics faropenem medoxomil and lenampicillin. {ECO:0000269|PubMed:20177059}. |
Q96ER3 | SAAL1 | S6 | ochoa | Protein SAAL1 (Synoviocyte proliferation-associated in collagen-induced arthritis protein 1) (SPACIA1) | Plays a role in promoting the proliferation of synovial fibroblasts in response to pro-inflammatory stimuli. {ECO:0000269|PubMed:22127701}. |
Q96NT5 | SLC46A1 | S6 | ochoa | Proton-coupled folate transporter (HsPCFT) (hPCFT) (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1) | Proton-coupled folate symporter that mediates folate absorption using an H(+) gradient as a driving force (PubMed:17129779, PubMed:17446347, PubMed:17475902, PubMed:19389703, PubMed:19762432, PubMed:25504888, PubMed:29344585, PubMed:30858177, PubMed:31494288, PubMed:31792273, PubMed:32893190, PubMed:34619546). Involved in the intestinal absorption of folates at the brush-border membrane of the proximal jejunum, and the transport from blood to cerebrospinal fluid across the choroid plexus (PubMed:17129779, PubMed:17446347, PubMed:17475902, PubMed:19389703, PubMed:25504888, PubMed:29344585, PubMed:30858177, PubMed:31494288, PubMed:32893190). Functions at acidic pH via alternate outward- and inward-open conformation states (PubMed:32893190, PubMed:34040256). Protonation of residues in the outward open state primes the protein for transport (PubMed:34040256). Binding of folate promotes breaking of salt bridge network and subsequent closure of the extracellular gate, leading to the inward-open state and release of protons and folate (PubMed:34040256). Also able to transport antifolate drugs, such as methotrexate and pemetrexed, which are established treatments for cancer and autoimmune diseases (PubMed:18524888, PubMed:19762432, PubMed:22345511, PubMed:25608532, PubMed:28802835, PubMed:29326243, PubMed:34040256, PubMed:34619546). Involved in FOLR1-mediated endocytosis by serving as a route of export of folates from acidified endosomes (PubMed:19074442). Also acts as a lower-affinity, pH-independent heme carrier protein and constitutes the main importer of heme in the intestine (PubMed:17156779). Imports heme in the retina and retinal pigment epithelium, in neurons of the hippocampus, in hepatocytes and in the renal epithelial cells (PubMed:32621820). Hence, participates in the trafficking of heme and increases intracellular iron content (PubMed:32621820). {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17156779, ECO:0000269|PubMed:17446347, ECO:0000269|PubMed:17475902, ECO:0000269|PubMed:18524888, ECO:0000269|PubMed:19074442, ECO:0000269|PubMed:19389703, ECO:0000269|PubMed:19762432, ECO:0000269|PubMed:22345511, ECO:0000269|PubMed:25504888, ECO:0000269|PubMed:25608532, ECO:0000269|PubMed:28802835, ECO:0000269|PubMed:29326243, ECO:0000269|PubMed:29344585, ECO:0000269|PubMed:30858177, ECO:0000269|PubMed:31494288, ECO:0000269|PubMed:31792273, ECO:0000269|PubMed:32621820, ECO:0000269|PubMed:32893190, ECO:0000269|PubMed:34040256, ECO:0000269|PubMed:34619546}.; FUNCTION: [Isoform 2]: Inactive isoform which is not able to mediate proton-coupled folate transport. {ECO:0000269|PubMed:17129779}. |
Q9BQI3 | EIF2AK1 | S6 | ochoa | Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (hHRI) (Hemin-sensitive initiation factor 2-alpha kinase) | Metabolic-stress sensing protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) in response to various stress conditions (PubMed:32132706, PubMed:32132707, PubMed:37327776, PubMed:37550454, PubMed:38340717). Key activator of the integrated stress response (ISR) required for adaptation to various stress, such as heme deficiency, oxidative stress, osmotic shock, mitochondrial dysfunction and heat shock (PubMed:32132706, PubMed:32132707, PubMed:37327776, PubMed:37550454, PubMed:38340717). EIF2S1/eIF-2-alpha phosphorylation in response to stress converts EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, leading to a global attenuation of cap-dependent translation, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activator ATF4, and hence allowing ATF4-mediated reprogramming (PubMed:32132706, PubMed:32132707, PubMed:37327776). Acts as a key sensor of heme-deficiency: in normal conditions, binds hemin via a cysteine thiolate and histidine nitrogenous coordination, leading to inhibit the protein kinase activity (By similarity). This binding occurs with moderate affinity, allowing it to sense the heme concentration within the cell: heme depletion relieves inhibition and stimulates kinase activity, activating the ISR (By similarity). Thanks to this unique heme-sensing capacity, plays a crucial role to shut off protein synthesis during acute heme-deficient conditions (By similarity). In red blood cells (RBCs), controls hemoglobin synthesis ensuring a coordinated regulation of the synthesis of its heme and globin moieties (By similarity). It thereby plays an essential protective role for RBC survival in anemias of iron deficiency (By similarity). Iron deficiency also triggers activation by full-length DELE1 (PubMed:37327776). Also activates the ISR in response to mitochondrial dysfunction: HRI/EIF2AK1 protein kinase activity is activated upon binding to the processed form of DELE1 (S-DELE1), thereby promoting the ATF4-mediated reprogramming (PubMed:32132706, PubMed:32132707). Also acts as an activator of mitophagy in response to mitochondrial damage: catalyzes phosphorylation of eIF-2-alpha (EIF2S1) following activation by S-DELE1, thereby promoting mitochondrial localization of EIF2S1, triggering PRKN-independent mitophagy (PubMed:38340717). {ECO:0000250|UniProtKB:Q9Z2R9, ECO:0000269|PubMed:32132706, ECO:0000269|PubMed:32132707, ECO:0000269|PubMed:32197074, ECO:0000269|PubMed:37550454, ECO:0000269|PubMed:38340717}. |
Q9BSA9 | TMEM175 | T6 | ochoa | Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175) (hTMEM175) | Proton-activated proton channel that catalyzes proton efflux from endosomes and lysosomes to maintain a steady-state pH (PubMed:35333573, PubMed:35750034, PubMed:37390818). Activated at low pH (under pH 4.6) by luminal side protons: selectively mediates lysosomal proton release from lysosomes, eliciting a proton leak that balances V-ATPase activity to maintain pH homeostasis (PubMed:35750034). Regulation of lumenal pH stability is required for autophagosome-lysosome fusion (PubMed:26317472, PubMed:32267231). Also acts as a potassium channel at higher pH, regulating potassium conductance in endosomes and lysosomes (PubMed:26317472, PubMed:28723891, PubMed:32228865, PubMed:32267231, PubMed:33505021). Constitutes the pore-forming subunit of the lysoK(GF) complex, a complex activated by extracellular growth factors (PubMed:33505021). The lysoK(GF) complex is composed of TMEM175 and AKT (AKT1, AKT2 or AKT3), a major target of growth factor receptors: in the complex, TMEM175 channel is opened by conformational changes by AKT, leading to its activation (PubMed:33505021). The lysoK(GF) complex is required to protect neurons against stress-induced damage (PubMed:33505021). {ECO:0000269|PubMed:26317472, ECO:0000269|PubMed:28723891, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32267231, ECO:0000269|PubMed:33505021, ECO:0000269|PubMed:35333573, ECO:0000269|PubMed:35750034, ECO:0000269|PubMed:37390818}. |
Q9BXP2 | SLC12A9 | S6 | ochoa | Solute carrier family 12 member 9 (Cation-chloride cotransporter 6) (hCCC6) (Cation-chloride cotransporter-interacting protein 1) (CCC-interacting protein 1) (hCIP1) (Potassium-chloride transporter 9) (WO3.3) | May be an inhibitor of SLC12A1. Seems to correspond to a subunit of a multimeric transport system and thus, additional subunits may be required for its function (PubMed:10871601). May play a role in lysosomal ion flux and osmoregulation (PubMed:38334070). {ECO:0000269|PubMed:10871601, ECO:0000269|PubMed:38334070}. |
Q9H6S0 | YTHDC2 | S6 | ochoa | 3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein 2) (hYTHDC2) | 3'-5' RNA helicase that plays a key role in the male and female germline by promoting transition from mitotic to meiotic divisions in stem cells (PubMed:26318451, PubMed:29033321, PubMed:29970596). Specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs, a modification present at internal sites of mRNAs and some non-coding RNAs that plays a role in the efficiency of RNA processing and stability (PubMed:26318451, PubMed:29033321). Essential for ensuring a successful progression of the meiotic program in the germline by regulating the level of m6A-containing RNAs (By similarity). Acts by binding and promoting degradation of m6A-containing mRNAs: the 3'-5' RNA helicase activity is required for this process and RNA degradation may be mediated by XRN1 exoribonuclease (PubMed:29033321). Required for both spermatogenesis and oogenesis (By similarity). {ECO:0000250|UniProtKB:B2RR83, ECO:0000269|PubMed:26318451, ECO:0000269|PubMed:29033321, ECO:0000269|PubMed:29970596}. |
Q9H9E3 | COG4 | S6 | ochoa | Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4) | Required for normal Golgi function (PubMed:19536132, PubMed:30290151). Plays a role in SNARE-pin assembly and Golgi-to-ER retrograde transport via its interaction with SCFD1 (PubMed:19536132). {ECO:0000269|PubMed:19536132, ECO:0000269|PubMed:30290151}. |
Q9NUE0 | ZDHHC18 | Y6 | ochoa | Palmitoyltransferase ZDHHC18 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 18) (DHHC-18) (Zinc finger DHHC domain-containing protein 18) | Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates, such as CGAS, HRAS and LCK (PubMed:23034182, PubMed:27481942, PubMed:35438208). Acts as a negative regulator of the cGAS-STING pathway be mediating palmitoylation and inactivation of CGAS (PubMed:35438208). May also have a palmitoyltransferase activity toward the beta-2 adrenergic receptor/ADRB2 and therefore regulate G protein-coupled receptor signaling (PubMed:27481942). {ECO:0000269|PubMed:23034182, ECO:0000269|PubMed:27481942, ECO:0000269|PubMed:35438208}. |
Q9NUU6 | OTULINL | S6 | ochoa | Inactive ubiquitin thioesterase OTULINL | Lacks deubiquitinase activity. {ECO:0000269|PubMed:31056421}. |
Q9NYF5 | FAM13B | S6 | ochoa | Protein FAM13B (GAP-like protein N61) | None |
Q9P0U4 | CXXC1 | S6 | ochoa | CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1) | Transcriptional activator that exhibits a unique DNA binding specificity for CpG unmethylated motifs with a preference for CpGG. {ECO:0000269|PubMed:21407193}. |
Q9ULD5 | ZNF777 | S6 | ochoa | Zinc finger protein 777 | May be involved in transcriptional repression (PubMed:31856708). Inhibits cell proliferation through CDKN1A/p21 induction by down-regulation of NIBAN1/FAM129A at low cell density (PubMed:25560148). {ECO:0000269|PubMed:25560148, ECO:0000269|PubMed:31856708}. |
Q9Y3Z3 | SAMHD1 | S6 | ochoa | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1) (hSAMHD1) | Protein that acts both as a host restriction factor involved in defense response to virus and as a regulator of DNA end resection at stalled replication forks (PubMed:19525956, PubMed:21613998, PubMed:21720370, PubMed:22056990, PubMed:23601106, PubMed:23602554, PubMed:24336198, PubMed:26294762, PubMed:26431200, PubMed:28229507, PubMed:28834754, PubMed:29670289). Has deoxynucleoside triphosphate (dNTPase) activity, which is required to restrict infection by viruses, such as HIV-1: dNTPase activity reduces cellular dNTP levels to levels too low for retroviral reverse transcription to occur, blocking early-stage virus replication in dendritic and other myeloid cells (PubMed:19525956, PubMed:21613998, PubMed:21720370, PubMed:22056990, PubMed:23364794, PubMed:23601106, PubMed:23602554, PubMed:24336198, PubMed:25038827, PubMed:26101257, PubMed:26294762, PubMed:26431200, PubMed:28229507). Likewise, suppresses LINE-1 retrotransposon activity (PubMed:24035396, PubMed:24217394, PubMed:29610582). Not able to restrict infection by HIV-2 virus; because restriction activity is counteracted by HIV-2 viral protein Vpx (PubMed:21613998, PubMed:21720370). In addition to virus restriction, dNTPase activity acts as a regulator of DNA precursor pools by regulating dNTP pools (PubMed:23858451). Phosphorylation at Thr-592 acts as a switch to control dNTPase-dependent and -independent functions: it inhibits dNTPase activity and ability to restrict infection by viruses, while it promotes DNA end resection at stalled replication forks (PubMed:23601106, PubMed:23602554, PubMed:29610582, PubMed:29670289). Functions during S phase at stalled DNA replication forks to promote the resection of gapped or reversed forks: acts by stimulating the exonuclease activity of MRE11, activating the ATR-CHK1 pathway and allowing the forks to restart replication (PubMed:29670289). Its ability to promote degradation of nascent DNA at stalled replication forks is required to prevent induction of type I interferons, thereby preventing chronic inflammation (PubMed:27477283, PubMed:29670289). Ability to promote DNA end resection at stalled replication forks is independent of dNTPase activity (PubMed:29670289). Enhances immunoglobulin hypermutation in B-lymphocytes by promoting transversion mutation (By similarity). {ECO:0000250|UniProtKB:Q60710, ECO:0000269|PubMed:19525956, ECO:0000269|PubMed:21613998, ECO:0000269|PubMed:21720370, ECO:0000269|PubMed:22056990, ECO:0000269|PubMed:23364794, ECO:0000269|PubMed:23601106, ECO:0000269|PubMed:23602554, ECO:0000269|PubMed:23858451, ECO:0000269|PubMed:24035396, ECO:0000269|PubMed:24217394, ECO:0000269|PubMed:24336198, ECO:0000269|PubMed:25038827, ECO:0000269|PubMed:26101257, ECO:0000269|PubMed:26294762, ECO:0000269|PubMed:26431200, ECO:0000269|PubMed:27477283, ECO:0000269|PubMed:28229507, ECO:0000269|PubMed:28834754, ECO:0000269|PubMed:29610582, ECO:0000269|PubMed:29670289}. |
A0A2R8Y4L2 | HNRNPA1L3 | S6 | Sugiyama | Heterogeneous nuclear ribonucleoprotein A1-like 3 (Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48) | None |
P28066 | PSMA5 | S6 | Sugiyama | Proteasome subunit alpha type-5 (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome subunit alpha-5) (alpha-5) (Proteasome zeta chain) | Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). {ECO:0000269|PubMed:15244466, ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-9929491 | SPOP-mediated proteasomal degradation of PD-L1(CD274) | 0.000389 | 3.410 |
R-HSA-9907900 | Proteasome assembly | 0.010237 | 1.990 |
R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | 0.005328 | 2.273 |
R-HSA-68949 | Orc1 removal from chromatin | 0.000742 | 3.130 |
R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | 0.010998 | 1.959 |
R-HSA-69002 | DNA Replication Pre-Initiation | 0.005376 | 2.270 |
R-HSA-9930044 | Nuclear RNA decay | 0.005898 | 2.229 |
R-HSA-69052 | Switching of origins to a post-replicative state | 0.001749 | 2.757 |
R-HSA-1236974 | ER-Phagosome pathway | 0.002993 | 2.524 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 0.008440 | 2.074 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 0.008440 | 2.074 |
R-HSA-68867 | Assembly of the pre-replicative complex | 0.003439 | 2.464 |
R-HSA-350562 | Regulation of ornithine decarboxylase (ODC) | 0.005610 | 2.251 |
R-HSA-8854050 | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 0.006802 | 2.167 |
R-HSA-174113 | SCF-beta-TrCP mediated degradation of Emi1 | 0.006802 | 2.167 |
R-HSA-9932298 | Degradation of CRY and PER proteins | 0.009140 | 2.039 |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | 0.009140 | 2.039 |
R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | 0.011389 | 1.944 |
R-HSA-4641258 | Degradation of DVL | 0.007438 | 2.129 |
R-HSA-1236978 | Cross-presentation of soluble exogenous antigens (endosomes) | 0.008100 | 2.092 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 0.002662 | 2.575 |
R-HSA-9031628 | NGF-stimulated transcription | 0.011785 | 1.929 |
R-HSA-186763 | Downstream signal transduction | 0.005328 | 2.273 |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | 0.007117 | 2.148 |
R-HSA-180585 | Vif-mediated degradation of APOBEC3G | 0.007117 | 2.148 |
R-HSA-4641257 | Degradation of AXIN | 0.007438 | 2.129 |
R-HSA-9762114 | GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | 0.007438 | 2.129 |
R-HSA-1236975 | Antigen processing-Cross presentation | 0.005254 | 2.279 |
R-HSA-69239 | Synthesis of DNA | 0.005134 | 2.290 |
R-HSA-180534 | Vpu mediated degradation of CD4 | 0.006193 | 2.208 |
R-HSA-75815 | Ubiquitin-dependent degradation of Cyclin D | 0.006494 | 2.187 |
R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | 0.006494 | 2.187 |
R-HSA-169911 | Regulation of Apoptosis | 0.006802 | 2.167 |
R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome | 0.009140 | 2.039 |
R-HSA-5610783 | Degradation of GLI2 by the proteasome | 0.009140 | 2.039 |
R-HSA-5658442 | Regulation of RAS by GAPs | 0.012595 | 1.900 |
R-HSA-9604323 | Negative regulation of NOTCH4 signaling | 0.008440 | 2.074 |
R-HSA-5362768 | Hh mutants are degraded by ERAD | 0.008787 | 2.056 |
R-HSA-202403 | TCR signaling | 0.005499 | 2.260 |
R-HSA-69206 | G1/S Transition | 0.008013 | 2.096 |
R-HSA-69242 | S Phase | 0.012674 | 1.897 |
R-HSA-9929356 | GSK3B-mediated proteasomal degradation of PD-L1(CD274) | 0.008100 | 2.092 |
R-HSA-5387390 | Hh mutants abrogate ligand secretion | 0.009865 | 2.006 |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | 0.010237 | 1.990 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 0.010614 | 1.974 |
R-HSA-8863678 | Neurodegenerative Diseases | 0.003549 | 2.450 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 0.003549 | 2.450 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 0.008487 | 2.071 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 0.004270 | 2.370 |
R-HSA-5678895 | Defective CFTR causes cystic fibrosis | 0.010614 | 1.974 |
R-HSA-69481 | G2/M Checkpoints | 0.008327 | 2.079 |
R-HSA-166520 | Signaling by NTRKs | 0.012674 | 1.897 |
R-HSA-1368108 | BMAL1:CLOCK,NPAS2 activates circadian expression | 0.006494 | 2.187 |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | 0.008440 | 2.074 |
R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | 0.008787 | 2.056 |
R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | 0.010614 | 1.974 |
R-HSA-5358351 | Signaling by Hedgehog | 0.010549 | 1.977 |
R-HSA-5632684 | Hedgehog 'on' state | 0.001629 | 2.788 |
R-HSA-9766229 | Degradation of CDH1 | 0.012187 | 1.914 |
R-HSA-69601 | Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | 0.010614 | 1.974 |
R-HSA-69613 | p53-Independent G1/S DNA Damage Checkpoint | 0.010614 | 1.974 |
R-HSA-9909396 | Circadian clock | 0.000929 | 3.032 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.012271 | 1.911 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 0.006802 | 2.167 |
R-HSA-8853659 | RET signaling | 0.007117 | 2.148 |
R-HSA-69541 | Stabilization of p53 | 0.008100 | 2.092 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 0.003925 | 2.406 |
R-HSA-9824272 | Somitogenesis | 0.010614 | 1.974 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 0.012187 | 1.914 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 0.012187 | 1.914 |
R-HSA-8953897 | Cellular responses to stimuli | 0.005990 | 2.223 |
R-HSA-9034793 | Activated NTRK3 signals through PLCG1 | 0.014490 | 1.839 |
R-HSA-167021 | PLC-gamma1 signalling | 0.014490 | 1.839 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 0.013429 | 1.872 |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins ... | 0.013855 | 1.858 |
R-HSA-69306 | DNA Replication | 0.013715 | 1.863 |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | 0.014286 | 1.845 |
R-HSA-9931269 | AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 0.013429 | 1.872 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 0.013855 | 1.858 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 0.014724 | 1.832 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 0.015167 | 1.819 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 0.013009 | 1.886 |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 0.013009 | 1.886 |
R-HSA-8948751 | Regulation of PTEN stability and activity | 0.013855 | 1.858 |
R-HSA-5358346 | Hedgehog ligand biogenesis | 0.013009 | 1.886 |
R-HSA-1227986 | Signaling by ERBB2 | 0.016997 | 1.770 |
R-HSA-9764561 | Regulation of CDH1 Function | 0.015616 | 1.806 |
R-HSA-351202 | Metabolism of polyamines | 0.016997 | 1.770 |
R-HSA-9026527 | Activated NTRK2 signals through PLCG1 | 0.017363 | 1.760 |
R-HSA-1251932 | PLCG1 events in ERBB2 signaling | 0.017363 | 1.760 |
R-HSA-1306955 | GRB7 events in ERBB2 signaling | 0.017363 | 1.760 |
R-HSA-8939902 | Regulation of RUNX2 expression and activity | 0.017468 | 1.758 |
R-HSA-9793380 | Formation of paraxial mesoderm | 0.017468 | 1.758 |
R-HSA-186797 | Signaling by PDGF | 0.017945 | 1.746 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 0.017945 | 1.746 |
R-HSA-9707616 | Heme signaling | 0.017945 | 1.746 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 0.017945 | 1.746 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.018357 | 1.736 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 0.018428 | 1.735 |
R-HSA-1234174 | Cellular response to hypoxia | 0.019409 | 1.712 |
R-HSA-8941855 | RUNX3 regulates CDKN1A transcription | 0.023085 | 1.637 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 0.023012 | 1.638 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.027085 | 1.567 |
R-HSA-5689603 | UCH proteinases | 0.025185 | 1.599 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 0.022482 | 1.648 |
R-HSA-453276 | Regulation of mitotic cell cycle | 0.022482 | 1.648 |
R-HSA-5654738 | Signaling by FGFR2 | 0.027439 | 1.562 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.026159 | 1.582 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 0.027439 | 1.562 |
R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | 0.029181 | 1.535 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 0.021956 | 1.658 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 0.029772 | 1.526 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 0.023012 | 1.638 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 0.021956 | 1.658 |
R-HSA-9013694 | Signaling by NOTCH4 | 0.024089 | 1.618 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 0.021956 | 1.658 |
R-HSA-5619084 | ABC transporter disorders | 0.026302 | 1.580 |
R-HSA-4086400 | PCP/CE pathway | 0.026302 | 1.580 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 0.023012 | 1.638 |
R-HSA-2262752 | Cellular responses to stress | 0.030128 | 1.521 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 0.030367 | 1.518 |
R-HSA-9675108 | Nervous system development | 0.030666 | 1.513 |
R-HSA-381038 | XBP1(S) activates chaperone genes | 0.031571 | 1.501 |
R-HSA-212718 | EGFR interacts with phospholipase C-gamma | 0.031607 | 1.500 |
R-HSA-9645723 | Diseases of programmed cell death | 0.032794 | 1.484 |
R-HSA-202424 | Downstream TCR signaling | 0.034036 | 1.468 |
R-HSA-176974 | Unwinding of DNA | 0.034431 | 1.463 |
R-HSA-9840373 | Cellular response to mitochondrial stress | 0.034431 | 1.463 |
R-HSA-381070 | IRE1alpha activates chaperones | 0.035296 | 1.452 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.036870 | 1.433 |
R-HSA-9027277 | Erythropoietin activates Phospholipase C gamma (PLCG) | 0.037247 | 1.429 |
R-HSA-8953854 | Metabolism of RNA | 0.037402 | 1.427 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 0.038524 | 1.414 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 0.039182 | 1.407 |
R-HSA-210990 | PECAM1 interactions | 0.040055 | 1.397 |
R-HSA-190236 | Signaling by FGFR | 0.040513 | 1.392 |
R-HSA-5610787 | Hedgehog 'off' state | 0.041860 | 1.378 |
R-HSA-382556 | ABC-family proteins mediated transport | 0.041860 | 1.378 |
R-HSA-9020702 | Interleukin-1 signaling | 0.042540 | 1.371 |
R-HSA-5654227 | Phospholipase C-mediated cascade; FGFR3 | 0.051208 | 1.291 |
R-HSA-5654228 | Phospholipase C-mediated cascade; FGFR4 | 0.053977 | 1.268 |
R-HSA-9912633 | Antigen processing: Ub, ATP-independent proteasomal degradation | 0.059490 | 1.226 |
R-HSA-5654219 | Phospholipase C-mediated cascade: FGFR1 | 0.062235 | 1.206 |
R-HSA-5654221 | Phospholipase C-mediated cascade; FGFR2 | 0.070422 | 1.152 |
R-HSA-6803529 | FGFR2 alternative splicing | 0.078539 | 1.105 |
R-HSA-418890 | Role of second messengers in netrin-1 signaling | 0.045648 | 1.341 |
R-HSA-9843745 | Adipogenesis | 0.068769 | 1.163 |
R-HSA-5655291 | Signaling by FGFR4 in disease | 0.051208 | 1.291 |
R-HSA-5637810 | Constitutive Signaling by EGFRvIII | 0.062235 | 1.206 |
R-HSA-5637812 | Signaling by EGFRvIII in Cancer | 0.062235 | 1.206 |
R-HSA-9034015 | Signaling by NTRK3 (TRKC) | 0.075841 | 1.120 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 0.083912 | 1.076 |
R-HSA-9648895 | Response of EIF2AK1 (HRI) to heme deficiency | 0.081230 | 1.090 |
R-HSA-9665348 | Signaling by ERBB2 ECD mutants | 0.064972 | 1.187 |
R-HSA-5637815 | Signaling by Ligand-Responsive EGFR Variants in Cancer | 0.073135 | 1.136 |
R-HSA-1236382 | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 0.073135 | 1.136 |
R-HSA-9948299 | Ribosome-associated quality control | 0.075360 | 1.123 |
R-HSA-909733 | Interferon alpha/beta signaling | 0.054716 | 1.262 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.047555 | 1.323 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.046722 | 1.330 |
R-HSA-210993 | Tie2 Signaling | 0.064972 | 1.187 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 0.044605 | 1.351 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 0.081287 | 1.090 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 0.052486 | 1.280 |
R-HSA-9682706 | Replication of the SARS-CoV-1 genome | 0.048432 | 1.315 |
R-HSA-9694686 | Replication of the SARS-CoV-2 genome | 0.062235 | 1.206 |
R-HSA-9679514 | SARS-CoV-1 Genome Replication and Transcription | 0.051208 | 1.291 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 0.057741 | 1.239 |
R-HSA-162909 | Host Interactions of HIV factors | 0.061602 | 1.210 |
R-HSA-9694682 | SARS-CoV-2 Genome Replication and Transcription | 0.067701 | 1.169 |
R-HSA-9711123 | Cellular response to chemical stress | 0.051831 | 1.285 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.073694 | 1.133 |
R-HSA-1474228 | Degradation of the extracellular matrix | 0.069582 | 1.158 |
R-HSA-6807070 | PTEN Regulation | 0.076198 | 1.118 |
R-HSA-422475 | Axon guidance | 0.082635 | 1.083 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 0.059275 | 1.227 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 0.076198 | 1.118 |
R-HSA-9758941 | Gastrulation | 0.085607 | 1.067 |
R-HSA-5218921 | VEGFR2 mediated cell proliferation | 0.086587 | 1.063 |
R-HSA-203927 | MicroRNA (miRNA) biogenesis | 0.086587 | 1.063 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 0.087355 | 1.059 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 0.088233 | 1.054 |
R-HSA-446652 | Interleukin-1 family signaling | 0.088233 | 1.054 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.088894 | 1.051 |
R-HSA-1643713 | Signaling by EGFR in Cancer | 0.089254 | 1.049 |
R-HSA-1989781 | PPARA activates gene expression | 0.090882 | 1.042 |
R-HSA-5655332 | Signaling by FGFR3 in disease | 0.091914 | 1.037 |
R-HSA-9006115 | Signaling by NTRK2 (TRKB) | 0.091914 | 1.037 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 0.092662 | 1.033 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 0.093555 | 1.029 |
R-HSA-109581 | Apoptosis | 0.097155 | 1.013 |
R-HSA-5654708 | Downstream signaling of activated FGFR3 | 0.097211 | 1.012 |
R-HSA-9006335 | Signaling by Erythropoietin | 0.097211 | 1.012 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 0.097211 | 1.012 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.098970 | 1.004 |
R-HSA-68962 | Activation of the pre-replicative complex | 0.099848 | 1.001 |
R-HSA-2424491 | DAP12 signaling | 0.099848 | 1.001 |
R-HSA-5654716 | Downstream signaling of activated FGFR4 | 0.099848 | 1.001 |
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 0.099848 | 1.001 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 0.099848 | 1.001 |
R-HSA-69190 | DNA strand elongation | 0.105099 | 0.978 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.106325 | 0.973 |
R-HSA-176187 | Activation of ATR in response to replication stress | 0.107713 | 0.968 |
R-HSA-1855204 | Synthesis of IP3 and IP4 in the cytosol | 0.107713 | 0.968 |
R-HSA-5689880 | Ub-specific processing proteases | 0.108187 | 0.966 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.108187 | 0.966 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.108187 | 0.966 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.110057 | 0.958 |
R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination | 0.110320 | 0.957 |
R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery | 0.112920 | 0.947 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.113767 | 0.944 |
R-HSA-913531 | Interferon Signaling | 0.113767 | 0.944 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.115512 | 0.937 |
R-HSA-5654696 | Downstream signaling of activated FGFR2 | 0.115512 | 0.937 |
R-HSA-5654687 | Downstream signaling of activated FGFR1 | 0.115512 | 0.937 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.117625 | 0.929 |
R-HSA-69275 | G2/M Transition | 0.120497 | 0.919 |
R-HSA-196757 | Metabolism of folate and pterines | 0.120674 | 0.918 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.122422 | 0.912 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 0.125806 | 0.900 |
R-HSA-201556 | Signaling by ALK | 0.125806 | 0.900 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.128241 | 0.892 |
R-HSA-202433 | Generation of second messenger molecules | 0.128361 | 0.892 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.130195 | 0.885 |
R-HSA-6811438 | Intra-Golgi traffic | 0.133449 | 0.875 |
R-HSA-5655302 | Signaling by FGFR1 in disease | 0.133449 | 0.875 |
R-HSA-376176 | Signaling by ROBO receptors | 0.137091 | 0.863 |
R-HSA-5654743 | Signaling by FGFR4 | 0.138509 | 0.859 |
R-HSA-1433557 | Signaling by SCF-KIT | 0.138509 | 0.859 |
R-HSA-72172 | mRNA Splicing | 0.139076 | 0.857 |
R-HSA-5357801 | Programmed Cell Death | 0.140071 | 0.854 |
R-HSA-2172127 | DAP12 interactions | 0.141028 | 0.851 |
R-HSA-373752 | Netrin-1 signaling | 0.141028 | 0.851 |
R-HSA-5654741 | Signaling by FGFR3 | 0.143539 | 0.843 |
R-HSA-1489509 | DAG and IP3 signaling | 0.143539 | 0.843 |
R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network | 0.148541 | 0.828 |
R-HSA-68882 | Mitotic Anaphase | 0.151120 | 0.821 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.152133 | 0.818 |
R-HSA-418990 | Adherens junctions interactions | 0.153148 | 0.815 |
R-HSA-5655253 | Signaling by FGFR2 in disease | 0.155990 | 0.807 |
R-HSA-8951664 | Neddylation | 0.156200 | 0.806 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.161314 | 0.792 |
R-HSA-162906 | HIV Infection | 0.162340 | 0.790 |
R-HSA-6798695 | Neutrophil degranulation | 0.163091 | 0.788 |
R-HSA-5654736 | Signaling by FGFR1 | 0.170697 | 0.768 |
R-HSA-177929 | Signaling by EGFR | 0.170697 | 0.768 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 0.172672 | 0.763 |
R-HSA-9772572 | Early SARS-CoV-2 Infection Events | 0.175543 | 0.756 |
R-HSA-157118 | Signaling by NOTCH | 0.175793 | 0.755 |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | 0.180362 | 0.744 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.183112 | 0.737 |
R-HSA-421270 | Cell-cell junction organization | 0.187316 | 0.727 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 0.187538 | 0.727 |
R-HSA-5688426 | Deubiquitination | 0.191534 | 0.718 |
R-HSA-1280218 | Adaptive Immune System | 0.198839 | 0.701 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.205557 | 0.687 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 0.208701 | 0.680 |
R-HSA-1266738 | Developmental Biology | 0.210357 | 0.677 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 0.211018 | 0.676 |
R-HSA-1226099 | Signaling by FGFR in disease | 0.213329 | 0.671 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.213466 | 0.671 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.215634 | 0.666 |
R-HSA-917937 | Iron uptake and transport | 0.215634 | 0.666 |
R-HSA-446728 | Cell junction organization | 0.216021 | 0.666 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.217094 | 0.663 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.220314 | 0.657 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 0.222508 | 0.653 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 0.224786 | 0.648 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.227844 | 0.642 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 0.229323 | 0.640 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 0.233834 | 0.631 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.234315 | 0.630 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.235395 | 0.628 |
R-HSA-195721 | Signaling by WNT | 0.237555 | 0.624 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.244830 | 0.611 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.253815 | 0.595 |
R-HSA-1500931 | Cell-Cell communication | 0.257047 | 0.590 |
R-HSA-162582 | Signal Transduction | 0.267439 | 0.573 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.269002 | 0.570 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 0.269002 | 0.570 |
R-HSA-1474244 | Extracellular matrix organization | 0.273326 | 0.563 |
R-HSA-5683057 | MAPK family signaling cascades | 0.290688 | 0.537 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 0.292258 | 0.534 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.294336 | 0.531 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.294336 | 0.531 |
R-HSA-211000 | Gene Silencing by RNA | 0.294336 | 0.531 |
R-HSA-2871796 | FCERI mediated MAPK activation | 0.304637 | 0.516 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.304637 | 0.516 |
R-HSA-212436 | Generic Transcription Pathway | 0.308829 | 0.510 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 0.314790 | 0.502 |
R-HSA-2029485 | Role of phospholipids in phagocytosis | 0.314790 | 0.502 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.314790 | 0.502 |
R-HSA-1592230 | Mitochondrial biogenesis | 0.318811 | 0.496 |
R-HSA-68886 | M Phase | 0.329567 | 0.482 |
R-HSA-6809371 | Formation of the cornified envelope | 0.332702 | 0.478 |
R-HSA-194138 | Signaling by VEGF | 0.336619 | 0.473 |
R-HSA-9664323 | FCGR3A-mediated IL10 synthesis | 0.338570 | 0.470 |
R-HSA-8956319 | Nucleotide catabolism | 0.344387 | 0.463 |
R-HSA-1640170 | Cell Cycle | 0.358615 | 0.445 |
R-HSA-74160 | Gene expression (Transcription) | 0.360593 | 0.443 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.361541 | 0.442 |
R-HSA-72766 | Translation | 0.379484 | 0.421 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.383731 | 0.416 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.384892 | 0.415 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.396325 | 0.402 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.396325 | 0.402 |
R-HSA-9664433 | Leishmania parasite growth and survival | 0.430935 | 0.366 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 0.430935 | 0.366 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 0.432613 | 0.364 |
R-HSA-9824446 | Viral Infection Pathways | 0.433641 | 0.363 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.474594 | 0.324 |
R-HSA-428157 | Sphingolipid metabolism | 0.476146 | 0.322 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.477694 | 0.321 |
R-HSA-6805567 | Keratinization | 0.485367 | 0.314 |
R-HSA-9679506 | SARS-CoV Infections | 0.504769 | 0.297 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 0.520687 | 0.283 |
R-HSA-15869 | Metabolism of nucleotides | 0.529139 | 0.276 |
R-HSA-8939211 | ESR-mediated signaling | 0.530534 | 0.275 |
R-HSA-597592 | Post-translational protein modification | 0.551344 | 0.259 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.561299 | 0.251 |
R-HSA-168249 | Innate Immune System | 0.562962 | 0.250 |
R-HSA-382551 | Transport of small molecules | 0.566526 | 0.247 |
R-HSA-449147 | Signaling by Interleukins | 0.567301 | 0.246 |
R-HSA-5663205 | Infectious disease | 0.568845 | 0.245 |
R-HSA-211945 | Phase I - Functionalization of compounds | 0.584355 | 0.233 |
R-HSA-199991 | Membrane Trafficking | 0.586618 | 0.232 |
R-HSA-9658195 | Leishmania infection | 0.588047 | 0.231 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.588047 | 0.231 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.633218 | 0.198 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.636485 | 0.196 |
R-HSA-8957322 | Metabolism of steroids | 0.637567 | 0.195 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.663627 | 0.178 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.677411 | 0.169 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 0.678374 | 0.169 |
R-HSA-109582 | Hemostasis | 0.688155 | 0.162 |
R-HSA-5653656 | Vesicle-mediated transport | 0.703855 | 0.153 |
R-HSA-168256 | Immune System | 0.729017 | 0.137 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.730479 | 0.136 |
R-HSA-1643685 | Disease | 0.750714 | 0.125 |
R-HSA-211859 | Biological oxidations | 0.801153 | 0.096 |
R-HSA-1430728 | Metabolism | 0.801927 | 0.096 |
R-HSA-556833 | Metabolism of lipids | 0.829176 | 0.081 |
R-HSA-392499 | Metabolism of proteins | 0.856855 | 0.067 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
KIS |
0.689 | 0.417 | 1 | 0.857 |
CDK18 |
0.685 | 0.443 | 1 | 0.863 |
HIPK2 |
0.684 | 0.430 | 1 | 0.846 |
CLK3 |
0.683 | 0.289 | 1 | 0.714 |
CDK19 |
0.680 | 0.431 | 1 | 0.871 |
P38D |
0.679 | 0.456 | 1 | 0.884 |
CDK17 |
0.678 | 0.440 | 1 | 0.861 |
CDK1 |
0.678 | 0.418 | 1 | 0.864 |
CDK16 |
0.678 | 0.426 | 1 | 0.859 |
CDK3 |
0.677 | 0.385 | 1 | 0.873 |
P38G |
0.676 | 0.442 | 1 | 0.872 |
CDK8 |
0.675 | 0.418 | 1 | 0.866 |
DYRK2 |
0.674 | 0.415 | 1 | 0.825 |
CDK5 |
0.674 | 0.404 | 1 | 0.847 |
HIPK1 |
0.672 | 0.396 | 1 | 0.815 |
DYRK1B |
0.670 | 0.399 | 1 | 0.837 |
SRPK1 |
0.669 | 0.248 | -3 | 0.748 |
DYRK4 |
0.668 | 0.408 | 1 | 0.873 |
ERK1 |
0.667 | 0.425 | 1 | 0.865 |
CDK7 |
0.666 | 0.410 | 1 | 0.866 |
CDK12 |
0.666 | 0.422 | 1 | 0.865 |
CDK13 |
0.666 | 0.412 | 1 | 0.863 |
JNK2 |
0.666 | 0.432 | 1 | 0.871 |
HIPK4 |
0.666 | 0.313 | 1 | 0.684 |
P38B |
0.666 | 0.430 | 1 | 0.868 |
CDK14 |
0.663 | 0.427 | 1 | 0.841 |
CDK10 |
0.663 | 0.397 | 1 | 0.846 |
P38A |
0.663 | 0.426 | 1 | 0.832 |
DYRK1A |
0.661 | 0.364 | 1 | 0.808 |
CLK2 |
0.661 | 0.242 | -3 | 0.765 |
SRPK2 |
0.660 | 0.206 | -3 | 0.691 |
JNK3 |
0.659 | 0.414 | 1 | 0.872 |
HIPK3 |
0.658 | 0.389 | 1 | 0.786 |
CLK1 |
0.658 | 0.266 | -3 | 0.728 |
CDK9 |
0.656 | 0.398 | 1 | 0.861 |
NLK |
0.656 | 0.344 | 1 | 0.722 |
COT |
0.652 | -0.031 | 2 | 0.692 |
CDKL5 |
0.652 | 0.167 | -3 | 0.751 |
SRPK3 |
0.652 | 0.194 | -3 | 0.715 |
CDK6 |
0.651 | 0.392 | 1 | 0.849 |
ERK2 |
0.650 | 0.397 | 1 | 0.832 |
DYRK3 |
0.650 | 0.308 | 1 | 0.788 |
PRP4 |
0.650 | 0.298 | -3 | 0.726 |
CDKL1 |
0.650 | 0.155 | -3 | 0.757 |
ICK |
0.650 | 0.245 | -3 | 0.775 |
ERK5 |
0.649 | 0.217 | 1 | 0.677 |
CLK4 |
0.648 | 0.221 | -3 | 0.754 |
CDK2 |
0.648 | 0.304 | 1 | 0.806 |
CDK4 |
0.648 | 0.404 | 1 | 0.860 |
MAK |
0.647 | 0.314 | -2 | 0.719 |
MOS |
0.645 | 0.062 | 1 | 0.544 |
JNK1 |
0.644 | 0.368 | 1 | 0.872 |
NUAK2 |
0.642 | 0.071 | -3 | 0.777 |
CDC7 |
0.638 | 0.007 | 1 | 0.529 |
MTOR |
0.638 | 0.070 | 1 | 0.543 |
MOK |
0.637 | 0.288 | 1 | 0.741 |
PKN3 |
0.635 | 0.029 | -3 | 0.756 |
PIM3 |
0.634 | -0.009 | -3 | 0.795 |
DSTYK |
0.633 | -0.051 | 2 | 0.679 |
MAPKAPK2 |
0.633 | 0.065 | -3 | 0.727 |
PIM1 |
0.633 | 0.038 | -3 | 0.769 |
PRPK |
0.633 | -0.055 | -1 | 0.575 |
BMPR1B |
0.632 | 0.032 | 1 | 0.489 |
MAPKAPK3 |
0.632 | 0.056 | -3 | 0.733 |
ERK7 |
0.631 | 0.152 | 2 | 0.472 |
ATR |
0.631 | -0.012 | 1 | 0.475 |
CAMK1B |
0.631 | 0.028 | -3 | 0.781 |
CHK1 |
0.631 | 0.130 | -3 | 0.737 |
PRKD1 |
0.630 | 0.030 | -3 | 0.756 |
NIK |
0.630 | 0.029 | -3 | 0.778 |
FAM20C |
0.629 | 0.042 | 2 | 0.545 |
LATS1 |
0.628 | 0.026 | -3 | 0.785 |
BMPR2 |
0.628 | -0.070 | -2 | 0.787 |
RAF1 |
0.628 | -0.095 | 1 | 0.436 |
PRKD2 |
0.628 | 0.045 | -3 | 0.747 |
AMPKA1 |
0.627 | 0.052 | -3 | 0.778 |
GRK7 |
0.627 | 0.014 | 1 | 0.455 |
AMPKA2 |
0.626 | 0.062 | -3 | 0.765 |
PKCD |
0.626 | -0.008 | 2 | 0.621 |
NUAK1 |
0.626 | 0.056 | -3 | 0.745 |
MST4 |
0.626 | -0.021 | 2 | 0.652 |
TSSK2 |
0.625 | 0.010 | -5 | 0.170 |
NEK6 |
0.625 | -0.034 | -2 | 0.766 |
TGFBR2 |
0.625 | -0.030 | -2 | 0.741 |
CHAK2 |
0.624 | -0.016 | -1 | 0.579 |
MLK1 |
0.624 | -0.068 | 2 | 0.619 |
GCN2 |
0.624 | -0.104 | 2 | 0.567 |
TBK1 |
0.624 | -0.101 | 1 | 0.364 |
IKKB |
0.624 | -0.101 | -2 | 0.647 |
DAPK2 |
0.623 | 0.011 | -3 | 0.772 |
PKN2 |
0.623 | -0.027 | -3 | 0.760 |
NDR2 |
0.623 | -0.053 | -3 | 0.779 |
ATM |
0.622 | -0.014 | 1 | 0.434 |
PDHK4 |
0.621 | -0.086 | 1 | 0.488 |
SKMLCK |
0.621 | -0.032 | -2 | 0.707 |
PKCG |
0.621 | -0.012 | 2 | 0.594 |
IRE2 |
0.621 | -0.034 | 2 | 0.609 |
CAMLCK |
0.620 | 0.003 | -2 | 0.695 |
MLK3 |
0.620 | -0.027 | 2 | 0.582 |
RSK2 |
0.620 | 0.006 | -3 | 0.752 |
ULK2 |
0.620 | -0.145 | 2 | 0.590 |
P90RSK |
0.620 | 0.008 | -3 | 0.757 |
IKKE |
0.620 | -0.108 | 1 | 0.365 |
PKCB |
0.619 | -0.007 | 2 | 0.580 |
NDR1 |
0.619 | -0.062 | -3 | 0.776 |
MLK4 |
0.619 | -0.039 | 2 | 0.557 |
LATS2 |
0.618 | -0.054 | -5 | 0.075 |
RSK3 |
0.618 | 0.000 | -3 | 0.737 |
PHKG1 |
0.618 | -0.001 | -3 | 0.769 |
TSSK1 |
0.618 | -0.002 | -3 | 0.794 |
ACVR2B |
0.618 | 0.001 | -2 | 0.754 |
P70S6KB |
0.618 | -0.016 | -3 | 0.755 |
CAMK2G |
0.618 | -0.090 | 2 | 0.602 |
ALK4 |
0.618 | -0.000 | -2 | 0.751 |
PRKD3 |
0.617 | 0.028 | -3 | 0.713 |
RIPK3 |
0.617 | -0.074 | 3 | 0.583 |
CAMK2A |
0.617 | 0.010 | 2 | 0.586 |
PDHK1 |
0.617 | -0.114 | 1 | 0.465 |
ANKRD3 |
0.617 | -0.071 | 1 | 0.453 |
MARK4 |
0.616 | -0.043 | 4 | 0.654 |
GRK1 |
0.616 | -0.052 | -2 | 0.670 |
CAMK2D |
0.616 | -0.020 | -3 | 0.745 |
ACVR2A |
0.616 | -0.008 | -2 | 0.747 |
TGFBR1 |
0.616 | 0.003 | -2 | 0.736 |
CAMK2B |
0.616 | -0.001 | 2 | 0.577 |
PKCA |
0.616 | -0.011 | 2 | 0.575 |
SBK |
0.616 | 0.124 | -3 | 0.615 |
WNK1 |
0.615 | -0.048 | -2 | 0.728 |
BMPR1A |
0.615 | 0.013 | 1 | 0.486 |
GRK5 |
0.615 | -0.118 | -3 | 0.724 |
IKKA |
0.614 | -0.081 | -2 | 0.665 |
DLK |
0.614 | -0.117 | 1 | 0.456 |
PINK1 |
0.614 | 0.090 | 1 | 0.559 |
MLK2 |
0.614 | -0.092 | 2 | 0.619 |
AKT2 |
0.614 | 0.048 | -3 | 0.694 |
PIM2 |
0.614 | 0.028 | -3 | 0.723 |
NEK7 |
0.613 | -0.135 | -3 | 0.675 |
PKCZ |
0.613 | -0.030 | 2 | 0.612 |
IRE1 |
0.613 | -0.053 | 1 | 0.375 |
GRK6 |
0.612 | -0.083 | 1 | 0.468 |
PLK1 |
0.612 | -0.064 | -2 | 0.755 |
SIK |
0.612 | 0.012 | -3 | 0.721 |
YSK4 |
0.612 | -0.077 | 1 | 0.393 |
CAMK4 |
0.611 | -0.025 | -3 | 0.745 |
MELK |
0.611 | 0.006 | -3 | 0.750 |
QSK |
0.611 | 0.004 | 4 | 0.656 |
MNK1 |
0.611 | -0.014 | -2 | 0.650 |
NEK9 |
0.611 | -0.110 | 2 | 0.615 |
TAO3 |
0.610 | -0.017 | 1 | 0.430 |
RSK4 |
0.610 | -0.002 | -3 | 0.740 |
PKR |
0.610 | -0.046 | 1 | 0.423 |
BCKDK |
0.610 | -0.100 | -1 | 0.571 |
PKCH |
0.610 | -0.029 | 2 | 0.562 |
ULK1 |
0.610 | -0.136 | -3 | 0.660 |
ALK2 |
0.610 | -0.008 | -2 | 0.724 |
HUNK |
0.609 | -0.125 | 2 | 0.582 |
DCAMKL1 |
0.608 | 0.007 | -3 | 0.759 |
MASTL |
0.608 | -0.148 | -2 | 0.716 |
AURC |
0.608 | -0.005 | -2 | 0.466 |
BRSK1 |
0.608 | 0.015 | -3 | 0.744 |
BRAF |
0.607 | -0.044 | -4 | 0.633 |
TTBK2 |
0.607 | -0.123 | 2 | 0.519 |
BUB1 |
0.606 | 0.075 | -5 | 0.173 |
CAMK1G |
0.605 | 0.014 | -3 | 0.728 |
MAPKAPK5 |
0.605 | 0.015 | -3 | 0.677 |
MEKK2 |
0.605 | -0.049 | 2 | 0.592 |
QIK |
0.605 | -0.046 | -3 | 0.726 |
CHAK1 |
0.605 | -0.086 | 2 | 0.617 |
MSK2 |
0.605 | -0.013 | -3 | 0.716 |
PAK1 |
0.605 | -0.054 | -2 | 0.633 |
CHK2 |
0.604 | 0.077 | -3 | 0.652 |
DCAMKL2 |
0.604 | 0.011 | -3 | 0.763 |
ZAK |
0.604 | -0.088 | 1 | 0.419 |
SGK3 |
0.604 | -0.005 | -3 | 0.718 |
MEK1 |
0.604 | -0.110 | 2 | 0.610 |
NIM1 |
0.604 | -0.084 | 3 | 0.612 |
MNK2 |
0.604 | -0.035 | -2 | 0.634 |
GSK3A |
0.604 | 0.058 | 4 | 0.236 |
PKACG |
0.604 | -0.048 | -2 | 0.539 |
GRK4 |
0.603 | -0.124 | -2 | 0.718 |
VRK2 |
0.603 | -0.092 | 1 | 0.530 |
PKCT |
0.603 | -0.026 | 2 | 0.566 |
MEKK1 |
0.603 | -0.084 | 1 | 0.423 |
PKACB |
0.602 | -0.000 | -2 | 0.478 |
PASK |
0.602 | -0.008 | -3 | 0.773 |
MARK3 |
0.602 | -0.023 | 4 | 0.597 |
MST3 |
0.602 | -0.039 | 2 | 0.643 |
TLK1 |
0.602 | -0.054 | -2 | 0.753 |
MYLK4 |
0.601 | -0.014 | -2 | 0.592 |
AKT1 |
0.601 | 0.026 | -3 | 0.703 |
MEKK3 |
0.601 | -0.103 | 1 | 0.418 |
CK2A2 |
0.601 | 0.010 | 1 | 0.458 |
MARK2 |
0.601 | -0.028 | 4 | 0.563 |
PAK3 |
0.601 | -0.074 | -2 | 0.633 |
PKCE |
0.601 | 0.014 | 2 | 0.584 |
DRAK1 |
0.601 | -0.091 | 1 | 0.411 |
DNAPK |
0.601 | -0.033 | 1 | 0.379 |
SMMLCK |
0.601 | 0.003 | -3 | 0.747 |
PLK3 |
0.600 | -0.078 | 2 | 0.569 |
CAMK1D |
0.600 | 0.037 | -3 | 0.679 |
PRKX |
0.600 | 0.017 | -3 | 0.694 |
CK1E |
0.600 | -0.011 | -3 | 0.506 |
CK1D |
0.600 | 0.015 | -3 | 0.462 |
NEK2 |
0.599 | -0.090 | 2 | 0.616 |
NEK5 |
0.599 | -0.071 | 1 | 0.404 |
PKCI |
0.599 | -0.009 | 2 | 0.593 |
EEF2K |
0.599 | 0.005 | 3 | 0.674 |
GRK2 |
0.599 | -0.056 | -2 | 0.594 |
WNK3 |
0.599 | -0.188 | 1 | 0.401 |
HRI |
0.599 | -0.070 | -2 | 0.779 |
MEK5 |
0.599 | -0.109 | 2 | 0.606 |
RIPK1 |
0.599 | -0.125 | 1 | 0.395 |
DAPK3 |
0.599 | 0.010 | -3 | 0.767 |
PLK4 |
0.599 | -0.098 | 2 | 0.452 |
PKN1 |
0.598 | 0.020 | -3 | 0.690 |
BRSK2 |
0.598 | -0.037 | -3 | 0.743 |
TAO2 |
0.598 | -0.026 | 2 | 0.657 |
PHKG2 |
0.598 | -0.022 | -3 | 0.738 |
PERK |
0.598 | -0.082 | -2 | 0.760 |
MPSK1 |
0.597 | 0.009 | 1 | 0.431 |
TNIK |
0.597 | 0.003 | 3 | 0.721 |
TLK2 |
0.597 | -0.094 | 1 | 0.376 |
GCK |
0.596 | -0.023 | 1 | 0.392 |
MARK1 |
0.596 | -0.032 | 4 | 0.620 |
MST2 |
0.596 | -0.058 | 1 | 0.408 |
SMG1 |
0.595 | -0.067 | 1 | 0.431 |
SSTK |
0.595 | -0.066 | 4 | 0.636 |
IRAK4 |
0.595 | -0.090 | 1 | 0.376 |
MSK1 |
0.595 | -0.014 | -3 | 0.719 |
PAK2 |
0.594 | -0.082 | -2 | 0.620 |
AKT3 |
0.594 | 0.031 | -3 | 0.656 |
SGK1 |
0.594 | 0.040 | -3 | 0.639 |
AURB |
0.594 | -0.031 | -2 | 0.464 |
NEK8 |
0.594 | -0.090 | 2 | 0.628 |
PKG2 |
0.594 | -0.034 | -2 | 0.468 |
CAMK1A |
0.594 | 0.042 | -3 | 0.667 |
CK1A2 |
0.593 | 0.001 | -3 | 0.467 |
PDK1 |
0.593 | -0.040 | 1 | 0.440 |
SNRK |
0.592 | -0.106 | 2 | 0.497 |
PAK6 |
0.592 | -0.031 | -2 | 0.544 |
KHS2 |
0.592 | 0.014 | 1 | 0.382 |
HGK |
0.592 | -0.026 | 3 | 0.709 |
WNK4 |
0.591 | -0.082 | -2 | 0.727 |
NEK11 |
0.591 | -0.074 | 1 | 0.417 |
GAK |
0.591 | -0.037 | 1 | 0.483 |
MINK |
0.591 | -0.043 | 1 | 0.375 |
AURA |
0.591 | -0.041 | -2 | 0.450 |
HASPIN |
0.591 | 0.059 | -1 | 0.568 |
MAP3K15 |
0.591 | -0.054 | 1 | 0.414 |
LKB1 |
0.590 | -0.040 | -3 | 0.689 |
KHS1 |
0.590 | -0.010 | 1 | 0.375 |
TTK |
0.590 | 0.019 | -2 | 0.769 |
DAPK1 |
0.589 | -0.003 | -3 | 0.750 |
CK2A1 |
0.589 | -0.007 | 1 | 0.443 |
P70S6K |
0.589 | -0.032 | -3 | 0.678 |
LRRK2 |
0.588 | -0.008 | 2 | 0.643 |
OSR1 |
0.588 | -0.033 | 2 | 0.589 |
GRK3 |
0.588 | -0.057 | -2 | 0.551 |
PKACA |
0.587 | -0.003 | -2 | 0.422 |
MEKK6 |
0.587 | -0.073 | 1 | 0.420 |
HPK1 |
0.587 | -0.034 | 1 | 0.384 |
MST1 |
0.586 | -0.075 | 1 | 0.379 |
ALPHAK3 |
0.584 | 0.008 | -1 | 0.530 |
PLK2 |
0.583 | -0.050 | -3 | 0.637 |
SLK |
0.583 | -0.043 | -2 | 0.630 |
NEK4 |
0.583 | -0.091 | 1 | 0.363 |
CAMKK1 |
0.583 | -0.124 | -2 | 0.645 |
CK1G1 |
0.583 | -0.049 | -3 | 0.523 |
PBK |
0.582 | -0.017 | 1 | 0.434 |
PAK5 |
0.582 | -0.035 | -2 | 0.508 |
LOK |
0.582 | -0.049 | -2 | 0.656 |
ROCK2 |
0.582 | -0.021 | -3 | 0.748 |
NEK1 |
0.581 | -0.061 | 1 | 0.376 |
IRAK1 |
0.580 | -0.135 | -1 | 0.446 |
YSK1 |
0.580 | -0.052 | 2 | 0.602 |
GSK3B |
0.580 | -0.034 | 4 | 0.225 |
DMPK1 |
0.580 | 0.014 | -3 | 0.742 |
CAMKK2 |
0.579 | -0.107 | -2 | 0.642 |
MRCKB |
0.579 | -0.014 | -3 | 0.711 |
NEK3 |
0.576 | -0.035 | 1 | 0.396 |
TTBK1 |
0.576 | -0.135 | 2 | 0.477 |
TAO1 |
0.576 | -0.028 | 1 | 0.366 |
PAK4 |
0.575 | -0.044 | -2 | 0.510 |
TAK1 |
0.574 | -0.126 | 1 | 0.407 |
AAK1 |
0.574 | 0.036 | 1 | 0.381 |
BIKE |
0.573 | -0.001 | 1 | 0.423 |
MRCKA |
0.573 | -0.039 | -3 | 0.723 |
MYO3B |
0.572 | -0.015 | 2 | 0.643 |
CRIK |
0.572 | 0.004 | -3 | 0.699 |
VRK1 |
0.571 | -0.165 | 2 | 0.659 |
MYO3A |
0.570 | -0.038 | 1 | 0.358 |
ASK1 |
0.570 | -0.077 | 1 | 0.418 |
YANK3 |
0.570 | -0.031 | 2 | 0.333 |
PDHK3_TYR |
0.569 | 0.038 | 4 | 0.714 |
ROCK1 |
0.568 | -0.027 | -3 | 0.726 |
STK33 |
0.567 | -0.116 | 2 | 0.471 |
TESK1_TYR |
0.567 | 0.021 | 3 | 0.697 |
RIPK2 |
0.567 | -0.145 | 1 | 0.384 |
MAP2K4_TYR |
0.566 | 0.032 | -1 | 0.606 |
PDHK4_TYR |
0.565 | 0.008 | 2 | 0.668 |
PKMYT1_TYR |
0.565 | 0.061 | 3 | 0.669 |
EPHA6 |
0.565 | 0.002 | -1 | 0.625 |
LIMK2_TYR |
0.565 | 0.052 | -3 | 0.765 |
PDHK1_TYR |
0.564 | 0.005 | -1 | 0.630 |
EPHB4 |
0.564 | 0.003 | -1 | 0.583 |
MAP2K6_TYR |
0.564 | 0.002 | -1 | 0.623 |
CK1A |
0.563 | -0.024 | -3 | 0.400 |
BMPR2_TYR |
0.563 | 0.015 | -1 | 0.634 |
BLK |
0.563 | 0.018 | -1 | 0.533 |
MEK2 |
0.563 | -0.174 | 2 | 0.575 |
JAK3 |
0.562 | -0.004 | 1 | 0.447 |
PINK1_TYR |
0.562 | -0.038 | 1 | 0.486 |
CSF1R |
0.562 | -0.002 | 3 | 0.675 |
LCK |
0.562 | 0.015 | -1 | 0.515 |
ABL2 |
0.562 | 0.005 | -1 | 0.495 |
ROS1 |
0.560 | -0.027 | 3 | 0.655 |
INSRR |
0.560 | -0.022 | 3 | 0.616 |
MST1R |
0.560 | -0.009 | 3 | 0.698 |
RET |
0.558 | -0.053 | 1 | 0.436 |
JAK2 |
0.558 | -0.010 | 1 | 0.452 |
LIMK1_TYR |
0.557 | -0.017 | 2 | 0.653 |
MAP2K7_TYR |
0.556 | -0.105 | 2 | 0.639 |
TYRO3 |
0.556 | -0.064 | 3 | 0.678 |
TXK |
0.556 | -0.030 | 1 | 0.502 |
PKG1 |
0.555 | -0.038 | -2 | 0.387 |
MET |
0.555 | -0.025 | 3 | 0.677 |
JAK1 |
0.555 | 0.014 | 1 | 0.396 |
TNNI3K_TYR |
0.555 | -0.003 | 1 | 0.459 |
KDR |
0.555 | -0.016 | 3 | 0.637 |
STLK3 |
0.554 | -0.113 | 1 | 0.380 |
EPHA4 |
0.553 | -0.007 | 2 | 0.586 |
KIT |
0.553 | -0.040 | 3 | 0.664 |
TYK2 |
0.553 | -0.083 | 1 | 0.427 |
FGR |
0.553 | -0.053 | 1 | 0.454 |
FGFR2 |
0.552 | -0.018 | 3 | 0.637 |
EPHB3 |
0.552 | -0.036 | -1 | 0.565 |
ABL1 |
0.552 | -0.019 | -1 | 0.472 |
FGFR1 |
0.552 | -0.003 | 3 | 0.641 |
EPHB2 |
0.552 | -0.029 | -1 | 0.561 |
ITK |
0.551 | -0.060 | -1 | 0.454 |
HCK |
0.551 | -0.031 | -1 | 0.500 |
FLT3 |
0.551 | -0.062 | 3 | 0.678 |
TNK2 |
0.550 | -0.034 | 3 | 0.635 |
EPHB1 |
0.549 | -0.059 | 1 | 0.491 |
PDGFRB |
0.549 | -0.079 | 3 | 0.678 |
FER |
0.549 | -0.064 | 1 | 0.504 |
TEK |
0.548 | -0.022 | 3 | 0.612 |
YES1 |
0.548 | -0.073 | -1 | 0.505 |
INSR |
0.547 | -0.049 | 3 | 0.606 |
FLT1 |
0.546 | -0.042 | -1 | 0.617 |
FGFR3 |
0.545 | -0.029 | 3 | 0.621 |
FYN |
0.544 | -0.028 | -1 | 0.511 |
BMX |
0.544 | -0.055 | -1 | 0.404 |
PTK2 |
0.544 | 0.015 | -1 | 0.600 |
TNK1 |
0.544 | -0.034 | 3 | 0.648 |
PDGFRA |
0.544 | -0.064 | 3 | 0.678 |
FRK |
0.544 | -0.028 | -1 | 0.529 |
ALK |
0.543 | -0.067 | 3 | 0.611 |
EPHA7 |
0.543 | -0.041 | 2 | 0.592 |
DDR1 |
0.543 | -0.117 | 4 | 0.608 |
EPHA8 |
0.543 | -0.013 | -1 | 0.568 |
NTRK3 |
0.543 | -0.046 | -1 | 0.533 |
LYN |
0.543 | -0.039 | 3 | 0.588 |
NEK10_TYR |
0.543 | -0.050 | 1 | 0.364 |
SYK |
0.543 | 0.000 | -1 | 0.599 |
EGFR |
0.543 | -0.032 | 1 | 0.385 |
EPHA5 |
0.542 | -0.025 | 2 | 0.571 |
YANK2 |
0.542 | -0.047 | 2 | 0.348 |
CK1G3 |
0.542 | -0.038 | -3 | 0.365 |
SRMS |
0.541 | -0.090 | 1 | 0.486 |
MERTK |
0.540 | -0.077 | 3 | 0.644 |
MATK |
0.539 | -0.054 | -1 | 0.462 |
TEC |
0.539 | -0.076 | -1 | 0.379 |
FLT4 |
0.538 | -0.064 | 3 | 0.581 |
AXL |
0.538 | -0.092 | 3 | 0.658 |
NTRK1 |
0.538 | -0.097 | -1 | 0.556 |
EPHA1 |
0.538 | -0.068 | 3 | 0.680 |
EPHA3 |
0.538 | -0.070 | 2 | 0.560 |
NTRK2 |
0.537 | -0.089 | 3 | 0.632 |
PTK2B |
0.537 | -0.044 | -1 | 0.422 |
FGFR4 |
0.537 | -0.033 | -1 | 0.513 |
ERBB4 |
0.537 | -0.021 | 1 | 0.405 |
ERBB2 |
0.536 | -0.076 | 1 | 0.417 |
ZAP70 |
0.536 | -0.003 | -1 | 0.506 |
DDR2 |
0.535 | -0.040 | 3 | 0.606 |
LTK |
0.535 | -0.105 | 3 | 0.608 |
CK1G2 |
0.535 | -0.039 | -3 | 0.444 |
IGF1R |
0.535 | -0.057 | 3 | 0.549 |
EPHA2 |
0.535 | -0.029 | -1 | 0.553 |
WEE1_TYR |
0.534 | -0.061 | -1 | 0.451 |
SRC |
0.532 | -0.076 | -1 | 0.488 |
MUSK |
0.531 | -0.054 | 1 | 0.355 |
BTK |
0.530 | -0.126 | -1 | 0.396 |
CSK |
0.527 | -0.078 | 2 | 0.584 |
PTK6 |
0.525 | -0.140 | -1 | 0.388 |
FES |
0.506 | -0.086 | -1 | 0.377 |